Parataxis Korea
파라택시스코리아 · 288330
Industrials Commercial Services · KOSDAQ
Market cap US$32M (₩44.1B)
Overview
Parataxis Korea operates two distinct businesses: a digital-asset division that holds Bitcoin as a strategic treasury asset and runs Bitcoin-mining infrastructure, and a biopharmaceutical division that researches and develops novel drugs for diseases such as idiopathic pulmonary fibrosis and lung cancer.
Its drug candidates are aimed at patients with high unmet medical needs, with the business model centered on licensing pipeline assets to partners in the near term and direct commercialization over the longer term. Listed on KOSDAQ, South Korea's tech and small-cap exchange, the company runs these two divisions in parallel, with the digital-asset arm being a recent addition funded through a capital raise.
Summary is AI-generated and may contain errors · figures from DART filings
Financials
Source: DART · FY ending Dec · latest FY2025Revenue
- FY2023US$72.5K
- FY2024US$1.6K
- FY2025US$6.5K
Operating profit
- FY2023−US$29.2M
- FY2024−US$13.8M
- FY2025−US$11M
Net income
- FY2023−US$30.8M
- FY2024−US$14.4M
- FY2025−US$23.4M
Key ratios (FY2025)
Why it matters
The digital-asset division was established using funds raised from a capital injection by Parataxis Holdings, making that entity a named funding source disclosed in the company's official filing.
Price charts coming soon
Interactive price history isn't here yet. Would you use it?